Dementia with Lewy bodies (DLB), the second most common type of dementia, requires a multifactorial approach to reduce symptoms.

A team of researchers at Washington University in St. Louis is in pursuit of translating induced, or synthetic, torpor into ...

Groundbreaking new Alzheimer’s treatment could give patients four years of better health. Patients who participated in the ...

An Alzheimer’s “wonder drug” can delay the progression of the disease by four years, according to a new study. Researchers ...

Patients in the earliest stages of Alzheimer's who received lecanemab showed improvement or no decline in cognitive function over a four-year trial period. The drug demonstrated particular promise for ...

These tau tangles damage the brain, disrupting how neurons work and eventually leading to cell death. Early in Alzheimer’s, ...

As her memory faded from Alzheimer’s disease in her late 50s, Tammy Maida began to lose track of her life. Car keys, ...

TORONTO -- Biomarkers pointing to increased risk for Alzheimer's disease were markedly reduced with the investigational cholesteryl ester transfer protein (CETP) inhibitor obicetrapib relative to ...